Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Arbor Biotechnologies
Arbor Biotechnologies
Vertex Leans into Gene Editing Space with Extended Arbor Pact
Vertex Leans into Gene Editing Space with Extended Arbor Pact
BioSpace
Vertex Pharmaceuticals
Arbor Biotechnologies
gene editing
Flag link:
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
MedCity News
Arbor Biotechnologies
MIT
liver disease
CNS disorders
funding
CRISPR
Flag link:
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Motley Fool
Vertex Pharmaceuticals
CRISPR
gene editing
Arbor Biotechnologies
Flag link:
Vertex boosts cell and genetic therapies toolkit in deal worth up to $1.2bn with Arbor
Vertex boosts cell and genetic therapies toolkit in deal worth up to $1.2bn with Arbor
Biopharma Reporter
Vertex
cell therapy
gene therapy
CRISPR
gene editing
Arbor Biotechnologies
Flag link:
